01 4BOEHRINGER INGELHEIM
01 410406172
01 4Blank
01 4Y
01 42030-06-15
Patent Expiration Date : 2030-06-15
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10406172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2733
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15
Patent Expiration Date : 2030-06-15
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10406172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2733
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15
Patent Expiration Date : 2030-06-15
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10406172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2733
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15
Patent Expiration Date : 2030-06-15
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10406172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2733
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15
